Form 4: Amylyx Pharmaceuticals Director Karen Firestone Buys $106,590 in Company Stock

Director Karen Firestone increased her stake in Amylyx Pharmaceuticals by purchasing 50,000 shares of common stock at an average price of $2.1318 on September 5, 2024.

Summary

• On September 5, 2024, Karen Firestone, a director of Amylyx Pharmaceuticals, Inc., purchased 50,000 shares of the company's common stock.
• The shares were bought at a weighted average price of $2.1318, with individual prices ranging from $2.11 to $2.15.
• Following the transaction, Firestone directly owns 55,000 shares of Amylyx Pharmaceuticals.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the amount is not significantly large relative to the company's overall market capitalization.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's valuation and future performance. It can be a positive signal, especially when a director increases their holdings.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates